))
EXTENDED: The Surprising Advantage of Transmission-Blocking Vaccines (with Ilinca Ciubotariu, Qixin He and Giovanna Carpi)
Manage episode 443028695 series 3531530
Content provided by Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
The World Health Organisation has recommended two licenced malaria vaccines. Those vaccines have been a long time coming - but are they the best?
In this extended episode of the Johns Hopkins Malaria Minute, we ask:
- Why is developing a malaria vaccine so challenging?
- How does antigen variation play affect the effectiveness of malaria vaccines?
- What are transmission-blocking vaccines (TBVs), and why haven't they gained much interest despite their potential?
With Ilinca Ciubotariu, Qixin He and Giovanna Carpi.
About The Podcast
The Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
84 episoade
Distribuie
